Phase 4
Completed N=41
Usefulness of Dexmedetomidine on Post-operative Pain Management in Patients With Interstitial Cystitis
Interstitial Cystitis
Source: ClinicalTrials.gov NCT01195116 ↗
Enrolled (actual)
41
Serious AEs
0.0%
Results posted
Mar 2015
Primary outcomePrimary: Change in Pain Score (1-10, 10 is Most Pain) From Baseline, to Average Post op Pain Score in PACU — -1.46; -.025 units on a scale
Summary
The purpose of this study is to assess the effects of dexmedetomidine while patients undergo treatment for Interstitial Cystitis (IC). The investigators goal is to demonstrate in patients with IC undergoing bladder hydrodistension that the use of dexmedetomidine as a supplemental anesthetic agent will result in better postoperative pain management.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in Pain Score (1-10, 10 is Most Pain) From Baseline, to Average Post op Pain Score in PACU |
-1.46; -.025 | — |
Eligibility Criteria
Inclusion Criteria
- Patients with a clinical diagnosis of IC scheduled for cystoscopy and hydrodistension for both diagnostic and therapeutic indications.
- 2. Gender of Patients: Male & female,Age of Patients: 18 and older
Exclusion Criteria
- Conduction disturbance (second degree AV block or greater), or previous reaction to medications used in this study. Patients receiving spinal anesthesia will not be included.
Data sourced from ClinicalTrials.gov (NCT01195116). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.